SCHEMBL8124328

SCHEMBL8124328

COc1cccc(CNc2n[nH]c(N)c2C#N)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PLA2G2A P14555 1/20 0.56
▸ APP P05067 1/20 0.52
▸ EGFR P00533 4/20 0.49
▸ ABL1 P00519 1/20 0.48
▸ CDK1 P06493 1/20 0.48
▸ AURKA O14965 1/20 0.47
▸ RPS6KB1 P23443 1/20 0.47
▸ HTT P42858 2/20 0.46
▸ KDR P35968 1/20 0.46
▸ KDM4E B2RXH2 1/20 0.45
▸ MAPK1 P28482 1/20 0.45
▸ SMN1; SMN2 Q16637 1/20 0.45
▸ MEN1 O00255 2/20 0.44
▸ KMT2A Q03164 2/20 0.44
▸ TP53 P04637 1/20 0.44
▸ PDE5A O76074 1/20 0.44
▸ ADORA3 P0DMS8 1/20 0.44
▸ ADORA2A P29274 1/20 0.44
▸ ADORA2B P29275 1/20 0.44
▸ ADORA1 P30542 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8124441 0.85 PLA2G2A (0.54) PLA2G2AAPPEGFRCDK1HTT
SCHEMBL6189743 0.82 HPGD (0.52) PLA2G2AAPPHTTKDM4EMAPK1
SCHEMBL8123985 0.80 PLA2G2A (0.65) PLA2G2AEGFRHTTKDRKDM4E
SCHEMBL8116158 0.80 EGFR (0.40) APPEGFRABL1CDK1AURKA
SCHEMBL8116157 0.80 EGFR (0.40) APPEGFRABL1CDK1AURKA
SCHEMBL8607191 0.77 AURKA (0.44) PLA2G2AAURKARPS6KB1GFER
SCHEMBL8124761 0.76 GAA (0.47) PLA2G2AAURKARPS6KB1HTTKDM4E
SCHEMBL8577411 0.76 AURKA (0.56) PLA2G2AAURKARPS6KB1GAAGFER
SCHEMBL5501933 0.74 ADORA1 (0.64) PLA2G2AHTTKDM4EMEN1KMT2A
SCHEMBL5044517 0.74 APP (0.53) APPEGFRHTTKDRTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0819129-B1 PYRAZOLE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF NOVARTIS AG (CH) 2000-08-02 — — EP disclosed
US-5981533-A INHIBIT THE TYROSINE KINASE ACTIVITY OF THE RECEPTOR FOR EPIDERMAL GROWTH FACTOR AND CAN BE USED IN THE CASE OF EPIDERMAL HYPERPROLIFERATION (PSORIASIS) AND AS ANTI-TUMOR AGENTS NOVARTIS AG (CH) 1999-11-09 — — US disclosed
WO-1998014449-A1 FUSED PYRAZOLE DERIVATIVES AND PROCESSES FOR THEIR PREPARATION NOVARTIS AG (CH) 1998-04-09 — — WO disclosed
EP-0819129-A1 PYRAZOLE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF Novartis AG (CH) 1998-01-21 — — EP disclosed
WO-1996031510-A1 PYRAZOLE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF NOVARTIS AG (CH) 1996-10-10 — — WO disclosed
Send feedback